These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19386495)

  • 1. Efficient synthesis of Idraparinux, the anticoagulant pentasaccharide.
    Chen C; Yu B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3875-9. PubMed ID: 19386495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Efficient Modular One-Pot Synthesis of Heparin-Based Anticoagulant Idraparinux.
    Dey S; Lo HJ; Wong CH
    J Am Chem Soc; 2019 Jul; 141(26):10309-10314. PubMed ID: 31244187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Modular Synthetic Approach to Isosteric Sulfonic Acid Analogues of the Anticoagulant Pentasaccharide Idraparinux.
    Mező E; Eszenyi D; Varga E; Herczeg M; Borbás A
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27845725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
    Petitou M; van Boeckel CA
    Angew Chem Int Ed Engl; 2004 Jun; 43(24):3118-33. PubMed ID: 15199558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile.
    Petitou M; Nancy-Portebois V; Dubreucq G; Motte V; Meuleman D; de Kort M; van Boeckel CA; Vogel GM; Wisse JA
    Thromb Haemost; 2009 Nov; 102(5):804-10. PubMed ID: 19888512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From heparin to synthetic antithrombotic oligosaccharides].
    Petitou M
    Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New synthesis of the anticoagulant pentasaccharide idraparinux and preparation of its analogues containing sulfonic acid moieties].
    Herczeg M
    Acta Pharm Hung; 2012; 82(3):113-9. PubMed ID: 23230650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis of 1,2-cis-amino containing oligosaccharides toward biological investigation.
    Manabe S
    Methods Enzymol; 2010; 478():413-35. PubMed ID: 20816492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide.
    Walenga JM; Jeske WP; Bara L; Samama MM; Fareed J
    Thromb Res; 1997 Apr; 86(1):1-36. PubMed ID: 9172284
    [No Abstract]   [Full Text] [Related]  

  • 10. High affinity interaction between a synthetic, highly negatively charged pentasaccharide and alpha- or beta-antithrombin is predominantly due to nonionic interactions.
    Hjelm R; Schedin-Weiss S
    Biochemistry; 2007 Mar; 46(11):3378-84. PubMed ID: 17323934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra.
    Langeslay DJ; Young RP; Beni S; Beecher CN; Mueller LJ; Larive CK
    Glycobiology; 2012 Sep; 22(9):1173-82. PubMed ID: 22593556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of idraparinux and idrabiotaparinux for anticoagulant therapy.
    Harenberg J
    Thromb Haemost; 2009 Nov; 102(5):811-5. PubMed ID: 19888513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Physicochemical Characterization of the Synthetic Anticoagulant Pentasaccharide Fondaparinux Sodium by Quantitative NMR and Single Crystal X-ray Analysis.
    Wildt W; Kooijman H; Funke C; Üstün B; Leika A; Lunenburg M; Kaspersen F; Kellenbach E
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28817073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale synthesis of 6-deoxy-6-sulfonatomethyl glycosides and their application for novel synthesis of a heparinoid pentasaccharide trisulfonic acid of anticoagulant activity.
    Mező E; Herczeg M; Eszenyi D; Borbás A
    Carbohydr Res; 2014 Mar; 388():19-29. PubMed ID: 24607537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activities of octyl 2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-beta-L-fucopyranoside.
    Hua Y; Du Y; Yu G; Chu S
    Carbohydr Res; 2004 Aug; 339(12):2083-90. PubMed ID: 15280053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.
    Chen Y; Lin L; Agyekum I; Zhang X; St Ange K; Yu Y; Zhang F; Liu J; Amster IJ; Linhardt RJ
    J Pharm Sci; 2017 Apr; 106(4):973-981. PubMed ID: 28007564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugars slide into heparin activity.
    Sinaÿ P
    Nature; 1999 Apr; 398(6726):377-8. PubMed ID: 10201366
    [No Abstract]   [Full Text] [Related]  

  • 18. Rational design of anticoagulant drugs using oligosaccharide chemistry.
    El Hadri A; Petitou M
    Chimia (Aarau); 2011; 65(1-2):14-7. PubMed ID: 21469438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of heparin partial structures and their binding activities to platelets.
    Koshida S; Suda Y; Sobel M; Ormsby J; Kusumoto S
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3127-32. PubMed ID: 10560738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural mobility of antithrombin and its modulation by heparin.
    Carrell R; Skinner R; Jin L; Abrahams JP
    Thromb Haemost; 1997 Jul; 78(1):516-9. PubMed ID: 9198206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.